{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:02:15Z","timestamp":1785510135169,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1177\/1933719115611751","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T01:44:28Z","timestamp":1451526268000},"page":"655-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Role of Anti-M\u00fcllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes"],"prefix":"10.1007","volume":"23","author":[{"given":"Daniela","family":"Romualdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Di Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"De Cicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Immediata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lanzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,30]]},"reference":[{"key":"23050655_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333: 853\u2013861.","journal-title":"N Engl J Med"},{"issue":"4","key":"23050655_CR2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2265.2010.03956.x","volume":"74","author":"R Pasquali","year":"2011","unstructured":"Pasquali R, Stener-Victorin E, Yildiz BO, et al. PCOS forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf). 2011;74(4):424\u2013433.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"23050655_CR3","first-page":"377","volume-title":"Diagnostic Criteria for Polycystic Ovary Syndrome: Towards A Rational Approach. Polycystic Ovary Syndrome 2011","author":"JK Zawadski","year":"2011","unstructured":"Zawadski JK, Dunaif A. Diagnostic Criteria for Polycystic Ovary Syndrome: Towards A Rational Approach. Polycystic Ovary Syndrome 2011. Boston, MA: Blackwell Scientific; 2011:377\u2013384."},{"issue":"1","key":"23050655_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"issue":"12","key":"23050655_CR5","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/humrep\/del306","volume":"21","author":"C Belosi","year":"2006","unstructured":"Belosi C, Selvaggi L, Apa R, et al. Is the PCOS diagnosis solved by ESHRE\/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum Reprod. 2006;21(12): 3108\u20133115.","journal-title":"Hum Reprod"},{"issue":"10","key":"23050655_CR6","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","volume":"113","author":"FJ Broekmans","year":"2006","unstructured":"Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006;113(10):1210\u20131217.","journal-title":"BJOG"},{"issue":"4","key":"23050655_CR7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1472-6483(10)60902-9","volume":"14","author":"F Geisth\u00f6vel","year":"2007","unstructured":"Geisth\u00f6vel F, Rabe T. The ESHRE\/ASRM consensus on polycystic ovary syndrome (PCOS)\u2014an extended critical analysis. Reprod Biomed Online. 2007;14(4):522\u2013535.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"23050655_CR8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544\u2013551.","journal-title":"Hum Reprod"},{"issue":"9","key":"23050655_CR9","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/del165","volume":"21","author":"IB Carlsson","year":"2006","unstructured":"Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O. Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod. 2006;21(9):2223\u20132227.","journal-title":"Hum Reprod"},{"issue":"11","key":"23050655_CR10","first-page":"2917","volume":"24","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. 2009;24(11):2917\u20132923.","journal-title":"The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome"},{"issue":"12","key":"23050655_CR11","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","volume":"88","author":"P Pigny","year":"2003","unstructured":"Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88(12):5957\u20135962.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"23050655_CR12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/REP-09-0415","volume":"139","author":"L Pellatt","year":"2010","unstructured":"Pellatt L, Rice S, Mason HD. Anti-M\u00fcllerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction. 2010;139(5):825\u2013833.","journal-title":"Reproduction"},{"issue":"2","key":"23050655_CR13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-57-2-320","volume":"57","author":"MI New","year":"1983","unstructured":"New MI, Lorenzen F, Lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab. 1983;57(2):320\u2013326.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1 pt 2","key":"23050655_CR14","first-page":"77","volume":"12","author":"AE Treloar","year":"1967","unstructured":"Treloar AE, Boynton RE, Behn BG, et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967;12(1 pt 2):77\u2013126.","journal-title":"Int J Fertil"},{"key":"23050655_CR15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440\u20131447.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"23050655_CR16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0026-0495(99)90028-8","volume":"48","author":"M Ciampelli","year":"1999","unstructured":"Ciampelli M, Fulghesu AM, Cucinelli F, et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism. 1999;48(2):167\u2013172.","journal-title":"Metabolism"},{"issue":"6","key":"23050655_CR17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF03351044","volume":"24","author":"M De Simone","year":"2001","unstructured":"De Simone M, Verrotti A, Iughetti L, et al. Increased visceral adipose tissue is associated with increased circulating insulin and decreased sex hormone binding globulin levels in massively obese adolescent girls. J Endocrinol Invest. 2001;24(6):438\u2013444.","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"23050655_CR18","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0002-8223(21)01887-3","volume":"90","author":"BB Peterkin","year":"1990","unstructured":"Peterkin BB. Dietary guidelines for Americans. J Am Diet Assoc. 1990;90(12): 1725\u20131727.","journal-title":"J Am Diet Assoc"},{"issue":"2","key":"23050655_CR19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0015-0282(01)01919-7","volume":"76","author":"AM Fulghesu","year":"2001","unstructured":"Fulghesu AM, Ciampelli M, Belosi C, et al. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma\/total area ratio. Fertil Steril. 2001;76(2):326\u2013323.","journal-title":"Fertil Steril"},{"issue":"5","key":"23050655_CR20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0015-0282(16)48552-3","volume":"43","author":"LF Orsini","year":"1985","unstructured":"Orsini LF, Venturoli S, Lorusso R, et al. Ultrasonic findings in polycystic ovarian disease. Fertil Steril. 1985;43(5):709\u2013714.","journal-title":"Fertil Steril"},{"issue":"3","key":"23050655_CR21","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1210\/jc.2004-0410","volume":"90","author":"M Ciampelli","year":"2005","unstructured":"Ciampelli M, Leoni F, Cucinelli F, et al. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J Clin Endocrinol Metab. 2005;90(3):1398\u20131406.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"23050655_CR22","first-page":"E214","volume":"237","author":"RA De Fronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214\u2013E223.","journal-title":"Am J Physiol"},{"issue":"1","key":"23050655_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/ENDO:30:1:3","volume":"30","author":"FJ Broekmans","year":"2006","unstructured":"Broekmans FJ, Fauser BC. Diagnostic criteria for polycystic ovarian syndrome. Endocrine. 2006;30(1):3\u201311.","journal-title":"Endocrine"},{"issue":"12","key":"23050655_CR24","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","volume":"91","author":"CK Welt","year":"2006","unstructured":"Welt CK, Gudmundsson JA, Arason G, et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab. 2006;91(12):4842\u20134848.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"23050655_CR25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u2013488.","journal-title":"Fertil Steril"},{"issue":"10","key":"23050655_CR26","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","volume":"91","author":"D Dewailly","year":"2006","unstructured":"Dewailly D, Catteau-Jonard S, Reyss AC, et al. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab. 2006;91(10):3922\u20133927.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"23050655_CR27","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","volume":"94","author":"E Guastella","year":"2010","unstructured":"Guastella E, Longo RA, Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril. 2010;94(6):2197\u20132201.","journal-title":"Fertil Steril"},{"issue":"2","key":"23050655_CR28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/humrep\/der418","volume":"27","author":"D Panidis","year":"2012","unstructured":"Panidis D, Tziomalos K, Misichronis G, et al. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod. 2012; 27(2):541\u2013549.","journal-title":"Hum Reprod"},{"issue":"2","key":"23050655_CR29","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","volume":"296","author":"A Piouka","year":"2009","unstructured":"Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2009;296(2):E238\u2013E243.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"23050655_CR30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12020-011-9437-6","volume":"39","author":"B Dilbaz","year":"2011","unstructured":"Dilbaz B, Ozkaya E, Cinar M, Cakir E, Dilbaz S. Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. Endocrine. 2011;39(3):272\u2013277.","journal-title":"Endocrine"},{"issue":"8","key":"23050655_CR31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1447-0756.2010.01478.x","volume":"37","author":"M Yilmaz","year":"2011","unstructured":"Yilmaz M, Isaoglu U, Delibas IB, Kadanali S. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. J Obstet Gynaecol Res. 2011;37(8): 1020\u20131026.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"23050655_CR32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejogrb.2011.01.023","volume":"156","author":"I Katsikis","year":"2011","unstructured":"Katsikis I, Karkanaki A, Misichronis G, Delkos D, Kandaraki EA, Panidis D. Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;156(2): 181\u2013185.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"23050655_CR33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fertnstert.2009.03.004","volume":"94","author":"V Desforges-Bullet","year":"2010","unstructured":"Desforges-Bullet V, Gallo C, Lefebvre C, Pigny P, Dewailly D, Catteau-Jonard S. Increased anti-Mullerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilisation. Fertil Steril. 2010;94(1): 198\u2013204.","journal-title":"Fertil Steril"},{"issue":"6","key":"23050655_CR34","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ajog.2008.01.037","volume":"198","author":"RP Kauffman","year":"2008","unstructured":"Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Am J Obstet Gynecol. 2008; 198(6):670.e1\u2013e7; discussion 670. e7\u2013e10.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"23050655_CR35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/humupd\/dml017","volume":"12","author":"SK Blank","year":"2006","unstructured":"Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update. 2006;12(4):351\u2013361.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"23050655_CR36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2013.05.019","volume":"170","author":"S Sahmay","year":"2013","unstructured":"Sahmay S, Atakul N, Oncul M, Tuten A, Aydogan B, Seyisoglu H. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):157\u2013161.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"23050655_CR37","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","volume":"26","author":"D Dewailly","year":"2011","unstructured":"Dewailly D, Gronier H, Poncelet E, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26(11):3123\u20133129.","journal-title":"Hum Reprod"},{"issue":"3","key":"23050655_CR38","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2005","unstructured":"Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2005; 91(3):941\u2013945.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"23050655_CR39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10815-012-9839-2","volume":"9","author":"Y Li","year":"2012","unstructured":"Li Y, Ma Y, Chen X, et al. Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism. J Assist Reprod Genet. 2012;9(10):1147\u20131151.","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"23050655_CR40","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2010-0334","volume":"95","author":"D Dewailly","year":"2010","unstructured":"Dewailly D, Pigny P, Soudan B, et al. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-M\u00fcllerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metab. 2010; 95(9):4399\u20134405.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"23050655_CR41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2012.03.059","volume":"98","author":"RL Rosenfield","year":"2012","unstructured":"Rosenfield RL, Wroblewski K, Padmanabhan V, et al. Antim\u00fcllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril. 2012;98(1): 242\u2013249.","journal-title":"Fertil Steril"},{"issue":"1","key":"23050655_CR42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","volume":"92","author":"L Pellatt","year":"2006","unstructured":"Pellatt L, Hanna L, Brincat M, et al. Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2006;92(1):240\u2013245.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"23050655_CR43","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370\u2013385.","journal-title":"Hum Reprod Update"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115611751.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719115611751","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719115611751\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719115611751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115611751.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:46:02Z","timestamp":1656812762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719115611751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["23050655"],"URL":"https:\/\/doi.org\/10.1177\/1933719115611751","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"30 December 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}